4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-20-002167
Options or other derivatives
- Director acquired 5,980 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Haddadin Yezan Munther · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-02 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +5,980 | $0.99 | $5,892 | 5,980 | D |
Loading xslF345X03/doc4.xml…